Latest Healthcare Policy news from across the web.
Last year's funding cuts to federal agencies that oversee foodborne illness outbreaks are being tested with the record cyclosporiasis outbreak in the U.S.
Read full article →Federal Medicaid dollars can no longer pay for gender-affirming care for youth. Doctors who treat trans kids say it will harm vulnerable people.
Read full article →Commure, which develops and sells AI products to clinics, has terminated a program that paid for referrals to new customers.
Read full article →Khartis raises oral immunology funds, Neurocrine drug safety concerns, and more biotech news from The Readout
Read full article →The health secretary headed to California to lay out the government's new approach to addiction treatment.
Read full article →Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each
Read full article →In this edition of STAT Health Tech: a deep dive into General Catalyst-backed Commure, and Medicare's tech incentives for AI devices.
Read full article →When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.
Read full article →A new study polled people with treatment-resistant depression about what matters to them when it comes to brain implants for mental health.
Read full article →As Medicare pays hospitals when they use newly-authorized AI devices, researchers say those payments could incentivize overuse.
Read full article →“The ability to prevent a deadly infectious disease is an extraordinary privilege,” writes infectious disease physician Krutika Kuppalli.
Read full article →One way to fight medical misinformation: make it easier for people to understand when they are being manipulated, write Paul Martin Jensen and Avi Tuschman.
Read full article →